Inovio said on Friday that the biotechnology company focused on deoxyribonucleic acid (DNA) medicine is planning to conduct the Phase-3 trial of its …
Shares of Inovio Pharmaceuticals dropped about 7% in Thursday’s pre-market trading after the biotech company priced its $150.5 million share offering.
Shares of Inovio Pharmaceuticals plunged 28.3% on Monday after the biotechnology company announced that the US Food and Drug Administration (FDA) halted the …
Inovio Pharmaceuticals Inc. plans to initiate Phase 2/3 study trials of INO-4800, its experimental vaccine candidate against the novel coronavirus, in September and …
Inovio Pharmaceuticals (INO) on Tuesday announced “positive” interim clinical data results of INO-4800, its experimental vaccine candidate against the novel coronavirus. Shares, however …
Inovio Pharmaceuticals (INO) has now initiated legal proceedings as an emergency action to compel the technology transfer required for the planned large-scale manufacture of …
Inovio Pharmaceuticals (INO) surged almost 10% after the company said that preclinical study data results of its potential vaccine candidate showed “robust” neutralizing …
“Coronavirus.” For most of this year, most people have been just focused on the one — the novel coronavirus dubbed SARS-CoV-19 that has …
Inovio Pharmaceuticals (INO) soared 5% in Tuesday’s after-market trading after the company announced positive interim data from a Phase 1/2a trial of DNA …
The World Health Organization (WHO) estimates there are approximately 70 potential vaccines for COVID-19 currently being developed across the globe. Inovio Pharmaceuticals’ (INO) …
